News

US judge sides with FDA's removal of Lilly's weight loss drug from shortage list
A U.S. federal judge has sided with a U.S. regulator's decision last year to take Eli Lilly’s blockbuster weight loss and ...
FDA crackdown on off-brand Ozempic products set to take effect, threatening supply and access for many
The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten this week with a federal deadline to ...
FDA halts sale of off-brand Ozempic and other GLP-1 drugs
A federal deadline ending sale of off-brand weight-loss and diabetes medications is now in effect, cutting off access to ...
Blocked From Selling Off-Brand Ozempic, Telehealth Startups Embrace a Less Effective Drug
As the FDA halts the sale of Ozempic and Zepbound copycats, online clinics have begun offering liraglutide, an older GLP-1 ...
Wellness companies eager to avoid WeightWatchers’ fate embrace weight-loss drugs
Some of the bankrupt company’s closest rivals, newer telehealth firms, face a new challenge of their own as federal ...
Cigna announces new deal for copay caps on Eli Lilly and Novo Nordisk weight loss drugs
Cigna’s pharmacy benefits unit Evernorth said the deal will bring prices down for employers and their workers.
pharmaphorum12d
More data back Zepbound over Wegovy for weight loss
Eli Lilly is ... to cut prescription drug prices in the US to the level paid by other comparable countries. Shares in ...